MADISON — The Wisconsin Economic Development Corp. has awarded a $750,000 grant to establish the Forward BIO Initiative – a new biomanufacturing center of excellence that will help bring groundbreaking research happening in Wisconsin out of the labs and into the marketplace, the WEDC announced today. The grant will be administered by BioForward Wisconsin.
The Forward BIO Initiative is a collaborative effort that will offer entrepreneurs and researchers the resources to effectively translate discoveries into commercial products in the emerging area of biomanufacturing — the advanced manufacturing of therapeutic medical devices, cells, tissues or pharmaceuticals, according to a WEDC news release. This initiative is committed to advancing Wisconsin’s position as a national leader in the biomanufacturing industry and features three components developed to reduce commercialization risk: the Forward BIO Institute, based at UW-Madison, Forward BIOLABS and BioForward Wisconsin.
“Just as the Global Water Center has put Milwaukee and Wisconsin on the map when it comes to water technology, we believe the Forward BIO Initiative, and promoting Wisconsin as a national biomanufacturing center of excellence, has the same potential for the state’s growing biohealth sector, which already includes 1,900 companies that employ more than 44,000 people,” said Vincent Rice, vice president of sector strategy development for WEDC, the state’s lead economic development organization, in the news release. “The partners have created a unique model that builds upon the respective strengths of each organization, focusing on a biohealth sector with significant opportunities for innovation, commercialization and growth.”
The collaboration guides projects from pre-incorporation within the Forward BIO Institute to the facilitation of efficient startup launches by Forward BIOLABS, with assistance and guidance from BioForward Wisconsin’s industry partners.
“BioForward is excited to be a partner in this strategic, united initiative to advance Wisconsin as a center of excellence for biomanufacturing,” said Lisa Johnson, CEO of BioForward, in the news release. “Through the Forward BIO Initiative, we will demonstrate how collaboration among public and private entities can advance workforce development, new company formations and industry partnerships.”
The Forward BIO Institute, based at the University of Wisconsin-Madison, will support transformative research in this emerging field, translate biomanufacturing technologies into the private sector, and establish public-private partnerships to connect UW inventors and researchers with industry leaders. The institute will also serve as a feeder of startups by providing a workforce skilled in both biomanufacturing and relevant business concepts. As part of this initiative, the institute will establish a new master’s degree program at UW-Madison in biomanufacturing innovation.
Forward BIOLABS will be a new, nonprofit shared laboratory facility that will provide fully supported lab and office space. The availability of the shared space will free up capital for startups by eliminating the need to spend their limited resources on leasing space, purchasing equipment and setting up a lab. The 8,700-square-foot facility will be in the University Research Park in Madison, with lab space for up to 20 scientists and common co-working space to allow members to collaborate.
BioForward Wisconsin will facilitate partnerships between government, academia and private industry, as well as marketing the economic impact of local biomanufacturing companies and Wisconsin’s biohealth industry. The organization will connect industry partners to the Forward BIO Institute and Forward BIOLABS to ensure corporate engagement with entrepreneurs.
To learn more about the Forward BIO Initiative and its partner organizations, visit www.forwardbioinitiative.org.
